Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP

Research Site, Taipei

Research Site, Taoyuan District

Research Site, Brussels

Research Site, Parkville

Research Site, Nedlands

Research Site, Bursa

Research Site, Stockholm

Research Site, Baltimore

Research Site, Erzurum

Research Site, Durham

Research Site, Madrid

Research Site, Chihuahua City

Research Site, Istanbul

Research Site, Ramat Gan

Research Site, Kansas City

Research Site, Beijing

Research Site, Guangzhou

Research Site, Shenzhen

Research Site, Shanghai

Research Site, Petah Tikva

Research Site, Ashkelon

Research Site, Brasília

Research Site, Porto Alegre

Research Site, Recife

Research Site, Salvador

Research Site, São Paulo

Research Site, São Paulo

Research Site, Calgary

Research Site, Winnepeg

Research Site, Helsinki

Research Site, Lodz

Research Site, Bucharest

Research Site, Vitoria-Gasteiz

Research Site, Ankara

Research Site, Birmingham